01
2024
-
07
2023
Received A+ round investment
The Phase I/II clinical trial of ZVS101e injection was completed for all participants
ZVS203e injection started IIT clinical trial and submitted IND application in US and China
ZVS203e injection obtained IND approvals from the U.S. FDA
Hot News
undefined
CHIGENOVO Co., Ltd. is an ophthalmic gene therapy company, a national high-tech enterprise focusing on genetic diagnosis of genetic eye diseases and the development of gene therapy drugs. It is committed to providing "one-stop" services for patients with genetic eye diseases.
HUATAO GROUP
Contact us
Telephone:400-6006223 010-82071936
Website:en.chinagene.cc
Address: Floor 4, Area D, Building 1, No.27 Life Garden Road, Zhongguancun Life Science Park, Changping District, Beijing
WeChat subscription account
